What is Synth Taxus?
Synth Taxus is dedicated to advancing pharmaceutical research and development through its expertise in chemical synthesis and manufacturing. The company specializes in creating complex compounds essential for drug discovery, with a notable history of applying its chemical synthesis discoveries to the production of established pharmaceuticals such as Taxol, Docetaxel, Cabazitaxel, and Milataxel. Its ongoing work also supports numerous other compounds currently in the pharmaceutical pipeline, aiming to benefit public health through innovative chemical solutions.
How much funding has Synth Taxus raised?
Synth Taxus has raised a total of $45K across 1 funding round:
Debt
$45K
Debt (2021): $45K with participation from PPP
What's next for Synth Taxus?
With the recent infusion of substantial expansion capital, Synth Taxus is strategically positioned to accelerate its manufacturing capabilities and broaden its R&D initiatives. The company's focus on critical pharmaceutical intermediates suggests a trajectory aimed at capturing a larger share of the drug development supply chain. Future endeavors will likely involve scaling production, enhancing proprietary synthesis technologies, and potentially forging new partnerships to bring novel therapeutics to market. The company's continued innovation in chemical synthesis is pivotal for its sustained growth and impact on public health.
See full Synth Taxus company page
